Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFUROXIME AXETIL vs CEMIPLIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFUROXIME AXETIL vs CEMIPLIMAB: Safety Overview

Metric CEFUROXIME AXETIL CEMIPLIMAB
Total FAERS Reports 2,878 1,020
Deaths Reported 144 175
Death Rate 5.0% 17.2%
Hospitalizations 755 651
Average Patient Age 54.5 yrs 68.9 yrs
% Female Patients 54.9% 36.6%
FDA Approval Date Apr 25, 2003 N/A
Manufacturer Major Pharmaceuticals Regeneron Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued N/A